No Data
No Data
Express News | Lipella Pharmaceuticals Inc - to Submit Ind Application for Phase 2B Trial in Late 2025
Express News | Lipella Pharmaceuticals Completes Enrollment in Phase 2a Trial of LP-310 for Oral Lichen Planus
Lipella Pharmaceuticals Co-Founder Michael Chancellor Featured on the Pharmaverse Podcast
Lipella Pharmaceuticals | 10-K: FY2024 Annual Report
Lipella Pharmaceuticals Files to Sell 5.62M Shares of Common Stock for Holders
Spartan Capital Securities, LLC Announces Key February Transactions